Violation Tracker Industry Summary Page

Industry: 
pharmaceuticals
Penalty Total since 2000: 
$40,181,040,154
Number of Records: 
877
Note: 
The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.

Top 10 Parent CompaniesTotal Penalty $Number of Records
Pfizer$4,747,652,94780
GlaxoSmithKline$4,422,266,05833
Johnson & Johnson$4,247,989,54954
Merck$3,310,180,72866
AbbVie$3,179,357,50750
Teva Pharmaceutical Industries$2,735,261,91850
Mallinckrodt$1,755,360,97919
Eli Lilly$1,641,265,17623
Bristol-Myers Squibb$1,554,891,42034
Novartis$1,543,646,94340


Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as CSV or XML
Company Parent Primary Offense Type Year Agency Penalty Amountsort icon
GlaxoSmithKline LLC GlaxoSmithKline off-label or unapproved promotion of medical products 2012 FDA $3,000,000,000
Pfizer Inc. Pfizer off-label or unapproved promotion of medical products 2009 FDA $2,300,000,000
Johnson & Johnson Johnson & Johnson off-label or unapproved promotion of medical products 2013 FDA $2,200,000,000
Mallinckrodt Mallinckrodt Controlled Substances Act violation 2020 MULTI-AG $1,600,000,000
Abbott Laboratories Inc. AbbVie off-label or unapproved promotion of medical products 2012 FDA $1,500,000,000
Eli Lilly and Company Eli Lilly off-label or unapproved promotion of medical products 2009 FDA $1,415,000,000
Cephalon, Inc. Teva Pharmaceutical Industries consumer protection violation 2015 FTC $1,200,000,000
Merck, Sharp & Dohme Merck off-label or unapproved promotion of medical products 2011 FDA $950,000,000
TAP Pharmaceutical Products Inc. Takeda Pharmaceutical False Claims Act and related 2001 DOJ_CIVIL $875,000,000
Pfizer Inc. Pfizer False Claims Act and related 2016 DOJ_CIVIL $784,600,000
Amgen Inc. Amgen off-label or unapproved promotion of medical products 2012 FDA $762,000,000
SB Pharmco Puerto Rico Inc. GlaxoSmithKline drug or medical equipment safety violation 2010 FDA $750,000,000
Serono, S.A. Merck KGaA (EMD) off-label or unapproved promotion of medical products 2005 FDA $704,000,000
Merck & Company Merck False Claims Act and related 2008 DOJ_CIVIL $650,000,000
Amgen Inc. Amgen off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $612,000,000
Allergan Inc. AbbVie off-label or unapproved promotion of medical products 2010 FDA $600,000,000
Abbott Laboratories and CG Nutritionals Abbott Laboratories False Claims Act and related 2003 DOJ_CIVIL $600,000,000
Johnson & Johnson Johnson & Johnson off-label or unapproved promotion of medical products 2013 MULTI-AG (*) $541,000,000
AstraZeneca LP AstraZeneca off-label or unapproved promotion of medical products 2010 FDA $520,000,000
Bristol-Myers Squibb Company Bristol-Myers Squibb off-label or unapproved promotion of medical products 2007 DOJ_CIVIL $515,000,000
Ranbaxy USA Inc. Sun Pharmaceuticals drug or medical equipment safety violation 2013 FDA $500,000,000
Schering-Plough Corporation Merck drug or medical equipment safety violation 2002 DOJ_CIVIL $500,000,000
Wyeth Pharmaceuticals Inc. Pfizer off-label or unapproved promotion of medical products 2013 FDA $490,900,000
GlaxoSmithKline GlaxoSmithKline off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $477,792,391
Mylan Inc. Mylan False Claims Act and related 2017 DOJ_CIVIL $465,000,000
Mylan Inc. Mylan False Claims Act and related 2017 MULTI-AG (*) $465,000,000
Purdue Frederick Company Inc. Purdue Pharma False Claims Act and related 2007 USAO $461,900,000
Schering-Plough Corporation Merck off-label or unapproved promotion of medical products 2006 USAO $435,000,000
Warner-Lambert Pfizer off-label or unapproved promotion of medical products 2004 FDA $430,000,000
Cephalon Inc Teva Pharmaceutical Industries off-label or unapproved promotion of medical products 2008 FDA $425,000,000
Novartis Pharmaceuticals Corporation Novartis off-label or unapproved promotion of medical products 2010 FDA $422,500,000
Janssen Pharmaceuticals, Inc. Johnson & Johnson off-label or unapproved promotion of medical products 2013 USAO $410,000,000
Novartis Pharmaceuticals Novartis kickbacks and bribery 2015 USAO $390,000,000
Wyeth Pharmaceuticals, Inc. Pfizer False Claims Act and related 2016 MULTI-AG (*) $371,351,180
Eli Lilly and Company Eli Lilly off-label or unapproved promotion of medical products 2009 MULTI-AG (*) $361,828,456
Actelion Pharmaceuticals US, Inc. Johnson & Johnson False Claims Act and related 2018 DOJ_CIVIL $360,000,000
AstraZeneca Pharmaceuticals LP AstraZeneca False Claims Act and related 2003 DOJ_CIVIL $354,900,000
Shire Pharmaceuticals LLC Takeda Pharmaceutical False Claims Act and related 2017 DOJ_CIVIL $350,000,000
Schering-Plough Corporation Merck kickbacks and bribery 2004 DOJ_CIVIL $345,000,000
Abbott Laboratories AbbVie off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $339,148,643
Pfizer, Inc. Pfizer kickbacks and bribery 2009 MULTI-AG (*) $331,485,170
Bristol-Myers Squibb Bristol-Myers Squibb fraud 2005 USAO $300,000,000
Schering-Plough Corporation Merck kickbacks and bribery 2004 MULTI-AG (*) $292,969,482
Merck Merck False Claims Act and related 2008 MULTI-AG (*) $290,000,000
Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Foreign Corrupt Practices Act 2016 DOJ_CRIMINAL $283,177,348
Dey Inc. Mylan False Claims Act and related 2010 DOJ_CIVIL $280,000,000
Roxane Laboratories Inc. Hikma Pharmaceuticals False Claims Act and related 2010 DOJ_CIVIL $280,000,000
Celgene Corp. Bristol-Myers Squibb False Claims Act and related 2017 USAO $280,000,000
Purdue Pharma Purdue Pharma Controlled Substances Act violation 2019 OK-AG $270,000,000
Ranbaxy Sun Pharmaceuticals drug or medical equipment safety violation 2013 MULTI-AG (*) $266,729,715
Serono Inc. Merck KGaA (EMD) off-label or unapproved promotion of medical products 2005 MULTI-AG (*) $262,000,000
Wyeth Pharmaceuticals, Inc. Pfizer off-label or unapproved promotion of medical products 2013 MULTI-AG (*) $257,400,000
Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Foreign Corrupt Practices Act 2016 SEC $236,000,000
Insys Therapeutics Insys Therapeutics False Claims Act and related 2019 DOJ_CIVIL $225,000,000
AstraZeneca Pharmaceuticals LP AstraZeneca off-label or unapproved promotion of medical products 2010 MULTI-AG (*) $218,092,993
United Therapeutics Corporation United Therapeutics False Claims Act and related 2017 DOJ_CIVIL $210,000,000
Elan Corporation PLC Perrigo off-label or unapproved promotion of medical products 2010 FDA $203,000,000
Merck Sharp & Dohme Corp. Merck off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $201,975,000
Sandoz Inc. Novartis price-fixing or anti-competitive practices 2020 DOJ_ANTITRUST $195,000,000
Endo Health Solutions Inc. Endo International off-label or unapproved promotion of medical products 2014 FDA $192,700,000
Aventis Pharmaceuticals Inc. Sanofi False Claims Act and related 2007 DOJ_CIVIL $190,000,000
Warner-Lambert Pfizer off-label or unapproved promotion of medical products 2004 MULTI-AG (*) $190,000,000
Bristol-Myers Squibb Bristol-Myers Squibb False Claims Act and related 2008 MULTI-AG (*) $187,000,000
Janssen Pharmaceuticals, Inc. Johnson & Johnson off-label or unapproved promotion of medical products 2012 MULTI-AG $181,000,000
Novartis Corporation Novartis employment discrimination 2010 private lawsuit-federal $175,000,000
Endo Health Solution Endo International off-label or unapproved promotion of medical products 2014 MULTI-AG (*) $173,000,000
Teva Pharmaceuticals Inc. Teva Pharmaceutical Industries False Claims Act and related 2010 MULTI-AG $169,000,000
Forest Pharmaceuticals Inc. AbbVie off-label or unapproved promotion of medical products 2011 FDA $164,000,000
SB Pharmco Puerto Rico Inc. GlaxoSmithKline drug or medical equipment safety violation 2010 MULTI-AG (*) $163,560,000
Purdue Frederick Company Inc. Purdue Pharma False Claims Act and related 2007 MULTI-AG (*) $160,000,000
Johnson & Johnson Johnson & Johnson off-label or unapproved promotion of medical products 2012 TX-AG $158,000,000
Par Pharmaceuticals, Inc. Endo International False Claims Act and related 2011 MULTI-AG $154,000,000
GlaxoSmithKline GlaxoSmithKline False Claims Act and related 2005 DOJ_CIVIL $150,000,000
Bristol-Myers Squibb Company Bristol-Myers Squibb accounting fraud or deficiencies 2004 SEC $150,000,000
Forest Pharmaceuticals Inc. AbbVie False Claims Act and related 2010 USAO $149,000,000
Valeant Pharmaceuticals International, Inc. Bausch Health investor protection violation 2017 MULTI-AG $145,000,000
Hoffman-LaRoche Roche price-fixing or anti-competitive practices 2000 MULTI-AG $142,494,000
Abbott Laboratories Inc. AbbVie False Claims Act and related 2010 DOJ_CIVIL $126,500,000
Warner Chilcott PLC AbbVie off-label or unapproved promotion of medical products 2015 FDA $125,000,000
Cephalon Teva Pharmaceutical Industries consumer protection violation 2016 MULTI-AG $125,000,000
King Pharmaceuticals Pfizer False Claims Act and related 2005 DOJ_CIVIL $124,000,000
King Pharmaceuticals Pfizer False Claims Act and related 2006 MULTI-AG (*) $124,000,000
Johnson & Johnson Johnson & Johnson drug or medical equipment safety violation 2019 MULTI-AG $120,000,000
Mylan Pharmaceuticals and UDL Laboratories Mylan False Claims Act and related 2009 DOJ_CIVIL $118,000,000
Mylan Pharmaceuticals, Inc. Mylan False Claims Act and related 2009 MULTI-AG (*) $118,000,000
Johnson & Johnson Johnson & Johnson drug or medical equipment safety violation 2019 MULTI-AG $116,860,000
Cephalon Inc. Teva Pharmaceutical Industries off-label or unapproved promotion of medical products 2008 MULTI-AG (*) $116,000,000
Avanir Pharmaceuticals Otsuka Pharmaceutical False Claims Act and related 2019 DOJ_CIVIL $115,874,895
AstraZeneca AstraZeneca False Claims Act and related 2018 TX-AG $110,000,000
Sanofi-Aventis U.S. Inc. Sanofi False Claims Act and related 2012 DOJ_CIVIL $109,000,000
Mylan Laboratories et al. Mylan price-fixing or anti-competitive practices 2000 MULTI-AG (*) $108,000,000
GlaxoSmithKline, LLC GlaxoSmithKline kickbacks and bribery 2014 MULTI-AG $105,000,000
Mylan Laboratories, Inc. Mylan consumer protection violation 2000 FTC $100,000,000
Mallinckrodt ARD Inc Mallinckrodt price-fixing or anti-competitive practices 2017 FTC $100,000,000
Astellas Pharma US Inc. Astellas Pharma False Claims Act and related 2019 DOJ_CIVIL $100,000,000
Bristol-Myers Squibb Co. Bristol-Myers Squibb price-fixing or anti-competitive practices 2003 MULTI-AG $100,000,000
Mallinckrodt plc Mallinckrodt price-fixing or anti-competitive practices 2017 MULTI-AG (*) $100,000,000
Novartis Novartis wage and hour violation 2012 private lawsuit-federal $99,000,000
Aventis Pharmaceutical Inc. Sanofi False Claims Act and related 2009 DOJ_CIVIL $95,500,000
Boehringer Ingelheim Pharmaceuticals Inc. Boehringer Ingelheim off-label or unapproved promotion of medical products 2012 FDA $95,000,000
Boehringer-Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim off-label or unapproved promotion of medical products 2012 MULTI-AG (*) $95,000,000
Download results as CSV or XML